chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received her second dose COVID vaccine (Pfizer LOT#: EW0171 EXP: 8/2021) at 1047. Patient alerted PHN. Patient stated that she was experiencing posterior neck tension located on the right side. Patient stated that this happened to her the first time she received the vaccine but did not think anything of it. Patient stated that she wanted to let PHN know since this symptom happened again. PHN assessed patient more. Patient stated that she also has a metallic taste in her mouth. PHN offered patient water. Patient agreed. EMT assessed patient a couple minutes later and patient stated that she felt light headed and dizzy. EMT alerted PHN. PHN asked EMT to take patients vital signs 1113. BP: 110/80, pulse: 80, O2: 98% and pain in neck was a 3/10 on pain scale. PHN asked patient to stay 30 more minutes for further observation. EMT assessed patient at 1123. Patient stated that she was feeling a lot better and that her symptoms had improved. Patient finished her 30 minute observation and patient stated that she was doing well and all symptoms had gone away. PHN educated patient on worsening signs of symptoms of side effects of vaccine and when to seek help from EMS. Patient verbalized understanding of education. Patient left vaccination site on her own with a steady gait at 1131.
Male patient of 73 years of age, oriented in time, place and person. Reports feeling discomfort in the throat area. Vital Signs Pulse: 78, B/P 140/80 Spo2 98%, Dextrose: 119. Consultation is made with the Medical Director, who indicates that she be administered Benadryl and Tylenol at 3:17pm.
Patient returned to the store today (11/15/17) and stated she had to pull over and give herself an EPIPEN shot because her throat closed. She said she went to Hospital and was given prednisone and BENADRYL.
Bad pain with injection-needle went too deep for teen female. Instant pain afterwards increasing. Next day can't move arm-pain spreading to shoulder and neck
This spontaneous report as received from a pharmacy technician refers to a 1 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 07-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.; tingly feeling; itchy; still has the tingly feeling, that called itchy before; the center is more pink and not so warm to the touch; feels like small bubbles under the skin; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.), PARAESTHESIA (tingly feeling), PRURITUS (itchy), PARAESTHESIA (still has the tingly feeling, that called itchy before) and RASH ERYTHEMATOUS (the center is more pink and not so warm to the touch) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.), PARAESTHESIA (tingly feeling), PRURITUS (itchy), PARAESTHESIA (still has the tingly feeling, that called itchy before), RASH ERYTHEMATOUS (the center is more pink and not so warm to the touch) and ECZEMA (feels like small bubbles under the skin). At the time of the report, RASH (rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.), PARAESTHESIA (tingly feeling), PRURITUS (itchy), PARAESTHESIA (still has the tingly feeling, that called itchy before), RASH ERYTHEMATOUS (the center is more pink and not so warm to the touch) and ECZEMA (feels like small bubbles under the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
During monitoring period post Pfizer COVID-19 vaccine, pt experienced itching on back and spreading "all over".  Medications Ordered/Given Per Protocol: Benadryl 25mg by mouth.
No adverse effects reported; one MMR II vial from a box of 10 vials was missing a flip cap; A dose of MMR II was administered to an unspecified patient by intramuscular route instead of subcutaneous route.; This spontaneous report as received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 14-JUN-2019, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R036582, expiration date 17-DEC-2020, (strength, dosage and frequency were not provided) for prophylaxis, by intramuscular route instead of subcutaneous route (incorrect route of product administration). No adverse effects were reported.  Follow-up information has been received from the pharmacist on 14-JUN-2019. The pharmacist called to report one measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) vial from a box of 10 vials was missing a flip cap. It was reported that the cap had fell off and was at the bottom inside the box. No doses were missed. The outcome of the product quality complaint and the relatedness between the event and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) were not reported.  Additional information has been received from a different pharmacist on 13-AUG-2019, who reported that the lot number for the compliant measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) with the missing flip cap, was R031628 (expiration date 01-NOV-2020).  Follow up information was received from a pharmacist on 15-AUG-2018. It was reported that the product complaint documented was discovered because the product information supplied in the carton of lot # R036582, was  accidentally misplaced by the pharmacy staff. Therefore, it was verified that the product did not have any quality defect.  Follow up information was received from a pharmacist on 14-AUG-2018. The pharmacist mentioned that when he initially picked the phone, he thought that the call was about the male patient (initially gender was unknown) who was having trouble with his insulin pen, but it was determined to be a misuse" an unrelated other company adverse event for the same patient for which product quality complaint was also filed. (Thus the patient's gender was updated to male and case was considered as valid.)
This RN received the COVID 19 vaccine 12-17-2020 at 1730 . Called manager at 1040 to report nausea, vomiting and terrible headache. No fever noted.
Initially headache and injection site inflammation, but by 3:00 PM the day after vaccination, I was experiencing muscle ache and chills. By 7:00 I was experiencing muscle weakness, nausea, joint stiffness. By 9:00 PM when I got up from lying down I felt like I might pass out and had to lie down on the floor. This happened again later when I went to use the bathroom. By 8:00 AM things had subsided and I was back to having a headache/neckache with pain at the injection site w/ redness about the size of a tennis ball. The nausea lasted much of that day. By Monday 11/17 I was feeling much better with just injection site sensitivity and redness.
Received vaccine on 8/24/17. On or around 9/10/17, pt began to develop a lump on her arm at the injection site. Lump continued to grow and became painful. Presented to Urg Care with mild tenderness, some redness, no induration. Xray showed soft tissue swelling in the deltoid area. Was advised rest and heat.
Pt. presented to ER on 1/15/08, given Dx of cellulitis to upper outer R arm.  Tx clindamycin 300 mg TID PO x7d.  Presented at office 1/16/08 with 6x4 cm erythematous, hot area to upper outer R arm.  Pt never experienced SOB, wheezing.
Sharp chest pain/Just began after 2nd dose. Pain more stabbing this time.; administration date: 27Mar2021, dose number: 1, administration date: 12May2021, dose number: 2; administration date: 27Mar2021, dose number: 1, administration date: 12May2021, dose number: 2; This is a spontaneous report from a non-contactable consumer or other non hcp(patient). A 19-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: not reported) via an unspecified route of administration, administered in Arm Left on 12May2021 at 19:15 (at the age of 19-years-old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Patient has no known allergies. Other medical history was none. Patient was non pregnant at the time of vaccination. Other medications in two weeks was BCP (birth control pills). The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having covid prior vaccination and has not been covid tested post vaccination. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: not reported) via an unspecified route of administration, administered in Arm Right on 27Mar2021 19:15 (at the age of 19-years-old) as dose 1, single for covid-19 immunisation. 12May2021 19:15 patient experienced off label use and inappropriate schedule of vaccine administered. Patient experienced Sharp chest pain beginning 4 days on 16May2021 after vaccine. Happened after 1st dose as dull aching in chest, but resolved in 2 hrs. Just began after 2nd dose. Pain more stabbing this time. The outcome of the event Chest pain was not recovered.No follow-up attempts are possible, information about lot/batch number cannot be obtained.
loose taste/lose taste; cannot smell anymore/lost his smell and cannot smell anymore; Back has been inflamed; This is a spontaneous report from a contactable consumer or other non-HCP (patient himself). A male patient of an unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number-UNKNOWN) via an unspecified route of administration on 06Aug2021 as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced loose taste/lose taste, cannot smell anymore/lost his smell and cannot smell anymore, back has been inflamed on Aug2021. Patient wants to know Is it common to lose taste after the shot or should he get a coronavirus test. The clinical outcome of the event back has been inflamed was unknown while that of the others was not recovered.  Follow-up (09Aug2021): This is a follow-up spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that: clinical information is merged and updated with the initial narrative.  Information about lot/batch has been requested.
None. Pt. received both PEDIARIX Hep B (single dose) on 10-15-08.
Arm hot, swelled and had knot.  Numbness & tingling in arm until knot dissolved.  3/26/08 reported swelling/tenderness at site.  4/7/08 numbness tingling in arm.
Inconsolable crying for 3 hours. Crying started 3 hours after vaccinations given.
Myalgia, Arthralgia, cold, tired Narrative:  Other Relevant History:
Swollen lymph node at base of skull in line with my left ear. Painful to the touch, approx. the size of a marble and lasted about a week and a half to two weeks.
2 hours after admin. Pt. became dizzy, headache, body ache, low temp, no appetite. Took Vicodin at 8PM, vomited at 2AM. Next day body ache, stayed in bed. Contacted MD 9/20 by phone, MD states pt has reaction to vaccine. Symptoms continued, pt see MD 10/2. Pt comes to pharmacy 10/25 to report reaction to RPh. Pt now feeling better.
She received the 2nd dose about two weeks ago; and the rash has not subsided as of today.; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (Spouse). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Expiry date: unknown), dose 2 via an unspecified route of administration on Feb2021 as dose 2, single for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Expiry date: unknown) dose 1 via an unspecified route of administration, administered on an unspecified date as dose 1, single for COVID-19 immunisation. The patient experienced a rash on her neck, arms, and wrists after she received her 1st dose of the vaccine about 5 weeks ago. She received the 2nd dose about two weeks ago; and the rash has not subsided as of today on an unspecified date of Feb2021. The outcome of the events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained. No further information is expected.
pt stated LA & hand "numb" & "tense", Lt & Rt hands warm & dry to touch, can wiggle Lt fingers, full ROM Lt hand, wrist, elbow & shoulder, ice to inject site, inj site s/ edema, bruising or redness
PATIENT had a seizure episode for about 15 seconds near the inside of the pharmacy. After patient had come back with consciousness, he explained that this hasnt happened since he was 15. Patient did not acknowledge that he had a history of seizures on the pre-check health list.
Client was given a dose of Pfizer pediatric dose 5-11 in Error. Per CDC guidelines client was then vaccinated with adult Pfiizer12+ booster dose.
inadvertently received MENACTRA on 24FEB2022 in the office which had expired on 18FEB2022 with no reported ae; Initial information received on 24-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 16 years old male patient who inadvertently received Menactra on 24-Feb-2022 in the office which had expired on 18-Feb-2022 with no reported adverse event (AE) while receiving vaccine meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Vaxero, Meningitis B, Flu Shot (Influenza Vaccine).   On 24-Feb-2022, the patient was administered 0.5 ml dose of suspect meningococcal A-C-Y-W135 (D Conj.) vaccine subcutaneously by a physician in the office (with lot number U6827BA, Expiry date: 18-Feb-2022) via intramuscular route in the left deltoid as prophylactic vaccination (immunisation).  An hour after the administration, the reporter informed that 2 patients had inadvertently received Menactra on 24-Feb-2022 which had expired on 18-Feb-2022. Patient was administered full dose of expired product (expired product administered) (latency: Same day) by the physician, but had not reported any adverse event. Enquiry was made if patient needed to be re-vaccinated  or if it was safe to give another full dose of Menactra right away since full doses were given on 24-Feb-2022.  Action taken with meningococcal vaccine (MENACTRA) was not applicable. It was not reported if the patient received a corrective treatment for the event  At time of reporting, the outcome was Unknown for the event  This was reported as potential AE because of use against local labelling. To be evaluated. No further information was provided by the reporter.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Acute onset of diverticulitis late afternoon/evening after injection without usual prodrome of symptoms.  Initial onset of LLQ abdominal to suprapubic pain about 4 hours after injection on 01/19/21, later that night chills, fever of up to 100.4° with worsening abdominal pain 8/10.  On 01/20/21 App used for video MD visit prescribed Augmentin 875/125, started later that day.  In bed 22 of 24 hours on 01/20/21 and 01/21/21.  Acute onset of non-traumatic R ankle /foot severe swelling and instability with severe pain, unable to bear weight, waking me up early morning 01/22/21.  Due to diverticulitis and unable to walk, stayed home, conservative care (RICE), ace bandage and Norco 5 mg 01/22/21-01/24/21.  X-rays R ankle/foot taken on 01/25/21 at Imaging .  Unable to get into PCP, went to Urgent Care, orthocast placed, prescribed Norco 5 mg.  Unable to talk with PCP, spoke with another Physician requesting MRI R foot/ankle and Podiatry and/or orthopedic Consult.  Still non-weight bearing on 01/27/21 but decreased swelling and R ankle/foot pain in cast.  Diverticulitis improved, no fever, on liquid diet.
Redness, inudration approximately 2" circumference and pain to touch. Started the evening of 1/26/03. Erythema covering left deltoid down to left elbow.
One week after MMR injection emp reported bilateral occipital lymph node enlargement, now resolved yesterday, 2 wks post vaccination emp reports that R index finger, R knee are stiff, top of R foot and lower back are painful. He also reports headache.
Rotavirus vaccine #1 given.  Child 14 weeks old.  A calendar had been consulted before vaccine was given but (apparently) figured incorrectly for the 12 weeks time frame.
This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 07Apr2021 at 15:45 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food or other products. Concomitant medications included vitamins (LOVEWELLNESS), from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 16Mar2021 at 15:30 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 17:45, the patient experienced pain at injection site after 2 hours of vaccine. On 08Apr2021 at 07:45, after 16 hours of vaccine, the patient experienced aches in joints, felt tired and run down, nasal congestion, headache and chills. The adverse events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events pain at injection site, aches in joints, felt tired and run down, nasal congestion, headache and chills were resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.
Arm pain which woke me up at 4:00 am. Headache, upset stomach, tiredness
Patient received vaccines at our office. Then she went home and 2 hours later started with rash on face and itchy. She complained with blurry vision.
My face started to swell and feel slightly numb. I could see my cheeks in my vision and my eyes were very puffy. I didn?t see medical attention because I could breathe normally but I self monitored for a few hours to make sure my  breathing was ok. I immediately took Benadryl and continued to monitor. It took about 3-4 days for the swelling to go away by massaging my face and continuing Benadryl.
Acute chest pain adverse reaction to COVID-19 vaccine.; This is a spontaneous report from a contactable consumer. This 14-year-old non pregnant female consumer (patient) reported that she received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 29Jun2021 09:30 (Batch/Lot Number: EW0162) as dose 1, single for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced acute chest pain adverse reaction to COVID-19 vaccine on an unspecified date. The outcome of the event was recovering.  Follow-up attempts are completed. No further information is expected.
shingles; blotchy rash on her stomach; achiness on left side of body /  soreness on left side of body/pain on right side of body; muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness on left side of body /  soreness on left side of body/pain on right side of body), MUSCLE SPASMS (muscle spasms), RASH MACULAR (blotchy rash on her stomach) and HERPES ZOSTER (shingles) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No reported medical history.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (achiness on left side of body /  soreness on left side of body/pain on right side of body) and MUSCLE SPASMS (muscle spasms). On 14-Mar-2021, the patient experienced RASH MACULAR (blotchy rash on her stomach). On 15-Mar-2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with MAGNESIUM SULFATE (EPSOM SALT) for General body pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, PAIN (achiness on left side of body /  soreness on left side of body/pain on right side of body), MUSCLE SPASMS (muscle spasms), RASH MACULAR (blotchy rash on her stomach) and HERPES ZOSTER (shingles) had not resolved.            No concomitant medications were reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Patient contact information updated. Treatment medications were added